These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8602211)

  • 1. Neuropharmacology. Psychoactive smoke.
    Glassman AH; Koob GF
    Nature; 1996 Feb; 379(6567):677-8. PubMed ID: 8602211
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of monoamine oxidase B in the brains of smokers.
    Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
    Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent data on monoamines of the brain].
    Vîlciu S; Manolescu J
    Neurol Psihiatr Neurochir; 1974; 19(1):1-10. PubMed ID: 4596187
    [No Abstract]   [Full Text] [Related]  

  • 4. [Smoking: one drug can hide another].
    Hounga RL; Launay M; Ramyead L; Restellini A; Restellini R; Cosson P; Soulié P
    Rev Med Suisse; 2009 Nov; 5(227):2416-7. PubMed ID: 20052842
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical aspects of schizophrenia.
    Lewis ME
    Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
    [No Abstract]   [Full Text] [Related]  

  • 6. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
    Castagnoli K; Murugesan T
    Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological aspects of the link between smoking and depression.
    Quattrocki E; Baird A; Yurgelun-Todd D
    Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase, tobacco smoking, and psychiatric disorders.
    Domino EF
    Biol Psychiatry; 1996 Sep; 40(5):433-4. PubMed ID: 8874851
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction.
    van Amsterdam J; Talhout R; Vleeming W; Opperhuizen A
    Life Sci; 2006 Oct; 79(21):1969-73. PubMed ID: 16884739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological mechanisms of individual predisposition to psychoactive drug abuse].
    Anokhina IP; Veretinskaia AG; Vasil'eva GN; Ovchinnikov IV
    Fiziol Cheloveka; 2000; 26(6):74-81. PubMed ID: 11153280
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions.
    Kumar P; Taha A; Sharma D; Kale RK; Baquer NZ
    Biogerontology; 2008 Aug; 9(4):235-46. PubMed ID: 18307051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rasagiline. A new monoamine oxidase b inhibitor for Parkinson treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2005 Jul; 28(7):224-7. PubMed ID: 16038119
    [No Abstract]   [Full Text] [Related]  

  • 15. Rasagiline (Azilect) for Parkinson's disease.
    Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):97-9. PubMed ID: 17149358
    [No Abstract]   [Full Text] [Related]  

  • 16. Mao-B inhibitor know-how: back to the pharm.
    Burke WJ
    Neurology; 2009 Dec; 73(23):2048; author reply 2048. PubMed ID: 19996086
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase and tobacco dependence.
    Lewis A; Miller JH; Lea RA
    Neurotoxicology; 2007 Jan; 28(1):182-95. PubMed ID: 16859748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of 3,4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissues by microcolumn high-performance liquid chromatography.
    Burke WJ; Chung HD; Li SW
    Anal Biochem; 1999 Aug; 273(1):111-6. PubMed ID: 10452806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.
    Naoi M; Maruyama W
    Expert Rev Neurother; 2009 Aug; 9(8):1233-50. PubMed ID: 19673610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between platelet MAO activity and personality--the effect of smoking and possible mechanisms behind the correlation.
    Oreland L; Garpenstrand H; Damberg M; Alm PO; Thorell LH; af Klinteberg B; Ekblom J
    Neurobiology (Bp); 1999; 7(2):191-203. PubMed ID: 10591052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.